Clinical trial Recruiting at 1 site Interventional Ages 35 and up

Lowering blood pressure after stroke with home monitoring and virtual group visits

Official title: A Hybrid Type 1 Randomized Trial for Improved Post-Stroke Hypertension: This Study Aims to Examine the Impact of Group Medical Visits and Home Blood Pressure Monitoring Versus Home Blood Pressure Monitoring Alone on the the Impact of Hypertension in Those With Recent Stroke.

Run by Massachusetts General Hospital · NCT07091851 · Data updated 2026-11-12

This will see if adding virtual group visits to home blood pressure checks helps lower blood pressure in people who had a recent mild-to-moderate stroke.

More Stroke trials

Quick facts

Study typeInterventional
Ages35 Years and up
SexAll
Enrollment50 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedSeptember 22, 2025
Main results expectedJanuary 30, 2028
Study endsApril 30, 2028
Registry record updatedSeptember 25, 2025
Trial IDNCT07091851 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with a recent mild-to-moderate ischemic or hemorrhagic stroke, a diagnosis of hypertension, English literacy, internet access, and an established primary care physician at MGH.

Probably not a fit

Patients with severe stroke, dementia, discharge to inpatient rehab or a skilled nursing facility, or those with moderate-to-severe aphasia without a caregiver to consent are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, hybrid Type 1 trial adapts two evidence-based approaches—home blood pressure monitoring (HBPM) and virtual group visits (VGVs)—for people recovering from stroke. Participants with mild-to-moderate ischemic or hemorrhagic stroke and hypertension will be randomly assigned to HBPM alone or HBPM combined with VGVs delivered via video. The team will use implementation-science methods (including the CFIR framework) to tailor the interventions and measure both blood pressure outcomes and pragmatic implementation measures. The goal is to determine whether the combined VGV-HBPM approach produces better blood pressure control and is feasible for stroke survivors.

Why it matters

Potential benefit: If successful, the combined approach could improve blood pressure control after stroke and lower the risk of having another stroke.

How similar studies have gone: HBPM and virtual group visit models have shown effectiveness in non-stroke populations, but their combined use has not been fully tested in stroke survivors.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Incident, mild to moderate, ischemic or hemorrhagic stroke (NIHSS≤15, ICH score≤3)
* history or new diagnosis of hypertension
* ability to read and speak English
* internet access
* established primary care physician at MGH

Exclusion Criteria:

* severe stroke (NIHSS\>15, ICH score\>3)
* discharge location to inpatient rehabilitation or skilled nursing facility
* dementia
* subjects with moderate to severe aphasia without a caregiver to consent on their behalf

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Rural Telemedicine-Enabled Care to Prevent Stroke in Older Adults in China

    A telemedicine-supported care model led by rural doctors will be tested to see if it can reduce stroke and heart problems in adults 65+ living in rural China.

    Recruiting at 2 sites Jiangsu Province (Suqian) Hospital · Suqian, Jiangsu and 1 other locations · NCT07628283

  • Managing multiple medications in older adults with chronic diseases

    This project will see if taking many different medicines changes the health outlook of people aged 65 and older who have chronic conditions.

    Recruiting Xijing Hospital · Xi'an, Shaanxi · NCT07180368

  • Deep phenotyping to explore recovery in young adults after stroke

    This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.

    Recruiting The Florey Institute of Neuroscience and Mental Health · Heidelberg, Victoria and 1 other locations · NCT07019493

  • Integrated care for older patients with atrial fibrillation

    This study is testing a new team-based care approach for older patients with atrial fibrillation and other health issues to see if it helps them manage their condition better than regular care.

    Recruiting at 50 sites Heart Care Foundation · Haskovo and 49 other locations · NCT06775028

  • Stem cell therapy for chronic stroke recovery

    This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.

    Recruiting Phase 2 Hokkaido University Hospital · Sapporo, Hokkaido · NCT06752720

  • Clevidipine to control high blood pressure after acute intracerebral hemorrhage

    This trial will test whether IV clevidipine helps adults with acute intracerebral hemorrhage reach and keep their target systolic blood pressure within 60 minutes better than other IV blood-pressure medicines.

    Recruiting at 21 sites Zeenat Qureshi Stroke Institute · Irvine, California and 20 other locations · NCT06402968

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.